×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Lokavant, Inc Innovation Theater: Applying the Scientific Method to Clinical Trials: Building the Evidence for AI-Driven Transformation
Session Chair(s)
Representative Invited
United States
Clinical trials rely on historical data, causing inefficiencies in site selection, patient matching, and execution. To drive change, the industry must apply the scientific method—testing AI-driven approaches to optimize outcomes. Lokavant leads this shift, improving protocol-matching accuracy by 20% and using predictive analytics. CEO Rohit Nambisan shares real-world evidence of AI’s impact on de-risking trials and accelerating enrollment. Learn why pharma leaders now see AI as a necessity.
Speaker(s)
Speaker
Rohit Nambisan
Lokavant, United States
CEO & Co-Founder
Have an account?